Logo


Ticker
Arrow Up NYSE Composite   NYSE   10972.74    -90.06 (-0.8%) Arrow Up Bank of America   BAC    15.80     -0.01 (-0.1%) Arrow Up Chesapeake Energy   CHK    15.75     -0.93 (-5.6%) Arrow Up Cobalt International Energy   CIE    10.00     -0.24 (-2.3%) Arrow Up Direxion Gold Miners Bull 3X   NUGT    13.12     -2.55 (-16.3%) Arrow Up Hewlett-Packard Co.   HPQ    34.21     -0.63 (-1.8%) Arrow Up SPDR S&P 500 E.T.F.   SPY    209.91     -0.75 (-0.4%) Arrow Up VS 3x Inv Nat Gas   DGAZ    7.07     -0.44 (-5.9%) Arrow Up VS 3x Long Crude   UWTI    2.95     +0.09 (+3.2%) Arrow Up NASDAQ Composite   NASDAQ   4963.53    +7.56 (+0.2%) Arrow Up Ambarella, Inc.   AMBA     66.98    +9.59 (+16.7%) Arrow Up Apple   AAPL     129.33    +0.87 (+0.7%) Arrow Up Aruba Networks   ARUN     24.44    -0.37 (-1.5%) Arrow Up Biocept, Inc.   BIOC     3.56    +0.40 (+12.7%) Arrow Up Clean Energy Fuels   CLNE     5.54    -0.47 (-7.8%) Arrow Up Home Loan Servicing Solutions   HLSS     18.42    +0.01 (+0.1%) Arrow Up Microsoft   MSFT     43.15    -0.70 (-1.6%) Arrow Up VS 2X VIX Short Term   TVIX     2.07    -0.01 (-0.5%) Arrow Up NYSE AMEX Composite   AMEX   2503.58   -18.79 (-0.7%) Arrow Up Daxor Corp   DXR    6.95    +0.18 (+2.7%) Arrow Up New Gold   NGD    3.66    -0.15 (-3.9%) Arrow Up VirnetX Holding   VHC    7.42    -0.13 (-1.7%) Arrow Up S&P/TSX Composite   TSX   15018.07    -216.27 (-1.4%) Arrow Up Altus Group   AIF    21.13    -0.87 (-4.0%) Arrow Up Bombardier Inc.   BBD.B    2.38    -0.22 (-8.5%) Arrow Up Element Financial   EFN    16.63    +0.61 (+3.8%) Arrow Up First Quantum Minerals   FM    15.25    -0.60 (-3.8%) Arrow Up HBP NYMEX Crude Oil Bull + ETF   HOU    8.46    +0.17 (+2.1%) Arrow Up Merus Labs International   MSL    2.66    +0.12 (+4.7%) Arrow Up Penn West Petroleum   PWT    2.38    -0.13 (-5.2%)

    

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
close window
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
NASDAQ BCRX
week ending
Friday Feb 27, 2015
   
Biocryst Pharmaceuticals
Trend Trend Counters Relative Strength  
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered.
Trend / Category
6/ 7
13 week Current wk Unusual Volume
93 +
n/a
  weeks in vs. S&P500  
Trading stats for the Week Stock Trends chart of Biocryst Pharmaceuticals $BCRX - click for more ST charts
  Close Range
$US 10.20 10.06 - 10.93
1 week %change 13 week %change
+0.5% -5.6%
Average Price
13 week MA 40 week MA
10.84 11.45
52-week range
7.29 - 14.62
Share Volume Transactions
4,298,900 27,193
Avg traded value Relative Volume
$1,613 7.2%
Total traded value
$43,848,780
Historical ST Data | ST Charts
Biocryst Pharmaceuticals (BCRX-Q)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Trades
Biotechnology
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 12/12 41 + 6.36 | 0.65 22nd Century Group XXII 0.82 nc 0.65 - 0.89 10944 2648
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 23/24 125 + 38.48 | 15.64 ACADIA Pharmaceuticals ACAD 37.97 +1.4 36.64 - 38.48 65220 45536
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/70 129 - 1.34 | 0.35 Acasti Pharma (D) ACST 0.55 -1.8 0.48 - 0.62 14159 1632
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/12 103 + 53.93 | 23.61 Acceleron Pharma XLRN 40.63 +1.6 38.62 - 41.61 7492 7374
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/37 93 + 16.87 | 2.45 Achillion Pharmaceuticals ACHN 12.14 -0.2 12.02 - 12.94 229255 92018
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/14 91 - 45.45 | 28.26 Acorda Therapeutics Inc. ACOR 33.84 -9.5 33.08 - 37.89 48375 37679
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 10/10 53 - 15.00 | 3.12 Actinium Pharmaceuticals ATNM 3.12 -11.1 3.12 - 3.76 20221 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 6998
76 - 14.00 | 9.38 Adma Biologics Inc. ADMA 9.54 -9.0 9.38 - 11.28 1628 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 790
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 283 + 13.74 | 2.46 Advaxis ADXS 9.00 +9.5 8.26 - 9.90 37988 14602
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/59 127 + 58.08 | 19.10 Aegerion Pharmaceuticals AEGR 27.20 +2.7 25.60 - 28.85 29533 20357
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/16 123 + 1.54 | 0.48 AEterna Zentaris (D) AEZS 0.65 +8.3 0.58 - 0.67 31395 3390
79 + 8.30 | 3.55 Affimed N.V. AFMD 6.17 +13.6 5.51 - 6.64 3339 1436
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 163 - 6.49 | 2.27 Agenus Inc. AGEN 4.90 -5.8 4.88 - 5.64 70745 25046
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/45 105 + 138.85 | 28.81 Agios Pharmaceuticals AGIO 107.28 +0.9 104.17 - 108.40 27781 26032
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/11 75 - 31.00 | 8.47 Akebia Therapeutics AKBA 9.26 -8.7 9.07 - 10.39 3662 2804
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/10 98 - 23.95 | 13.73 Albany Molecular Research AMRI 16.22 -0.3 15.91 - 16.43 14425 10624
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 8/40 200 + 24.79 | 3.12 Alcobra Ltd. ADHD 7.53 +1.4 7.06 - 8.30 16603 8096
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/4 162 - 32.30 | 9.50 Alder BioPharmaceuticals, Inc. ALDR 26.88 -1.9 26.49 - 29.16 8434 7650
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/5 139 - 13.50 | 3.00 Aldeyra Therapeutics ALDX 10.20 -2.9 9.62 - 10.70 567 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 351
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/89 91 - 203.30 | 136.37 Alexion Pharmaceuticals ALXN 180.37 -3.0 179.44 - 188.35 42398 39930
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/20 99 - 111.49 | 47.03 Alnylam Pharmaceuticals ALNY 101.53 -0.8 100.00 - 107.80 30333 28827
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/31 94 + 173.14 | 108.20 Amgen AMGN 157.72 nc 155.74 - 159.40 142694 105722
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/35 109 + 9.63 | 1.77 Amicus Therapeutics FOLD 8.76 +0.7 8.18 - 8.92 47138 29564
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 26/27 124 + 44.64 | 13.19 Anacor Pharmaceuticals, Inc. ANAC 43.50 nc 42.47 - 44.64 19114 14535
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/16 122 - 71.78 | 19.90 ANI Pharmaceuticals ANIP 67.36 -1.9 66.31 - 71.78 12397 11973
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/21 96 - 51.40 | 34.16 Anika Therapeutics ANIK 39.92 -9.4 38.12 - 45.35 14338 12044
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/10 99 - 34.37 | 11.10 Applied Genetic Technologies AGTC 20.29 -10.7 20.22 - 23.41 8814 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2794
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 143 + 23.82 | 9.20 Aratana Therapeutics PETX 19.26 +13.4 16.57 - 19.40 15841 11964
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/38 84 + 2.38 | 0.65 ARCA biopharma (D) ABIO 0.70 nc 0.65 - 0.84 26265 3077
58 - 35.48 | 11.37 Ardelyx, Inc. ARDX 15.75 -8.3 14.78 - 17.45 3314 2780
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/32 106 - 7.24 | 3.26 Arena Pharmaceuticals ARNA 4.51 -3.0 4.33 - 4.78 253872 71316
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/9 112 + 8.85 | 4.90 ARIAD Pharmaceuticals ARIA 8.13 +0.9 7.59 - 8.35 369253 138148
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/84 140 + 2.31 | 1.04 Arqule Inc. ARQL 1.88 +39.3 1.31 - 2.10 71181 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 13861
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 194 - 8.55 | 2.98 Array BioPharma ARRY 7.96 -3.4 7.76 - 8.51 140450 65434
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/35 127 + 27.63 | 4.95 Arrowhead Research ARWR 7.53 +2.0 7.21 - 8.06 77450 36965
0 - 21.97 | 17.00 Ascendis Pharma A/S ASND 17.73 -8.3 17.54 - 20.00 3511 1822
100 + 5.95 | 3.05 Asterias Biotherapeutics AST 3.98 +7.0 3.73 - 4.20 1263 535
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 178 + 3.93 | 1.08 Athersys Inc. ATHX 2.59 +9.3 2.24 - 2.76 60337 15028
90 - 62.48 | 22.00 Avalanche Biotechnologies AAVL 36.18 -9.7 35.57 - 40.21 10684 8608
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/175 138 + 1.96 | 0.61 AVEO Pharmaceuticals (D) AVEO 1.25 +34.4 0.86 - 1.29 46099 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 6806
0 + 33.63 | 18.20 Bellicum Pharmaceuticals, Inc. BLCM 23.22 +10.3 21.49 - 24.55 18927 11227
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 15/37 92 - 14.03 | 5.13 BIND Therapeutics BIND 6.06 -5.6 5.91 - 6.48 9118 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 4964
97 - 11.00 | 4.50 Bio Blast Pharma Ltd. ORPN 6.78 -1.9 6.27 - 7.49 1181 637
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/35 105 + 99.15 | 82.63 Bio-Techne Corp. TECH 97.53 +1.2 96.02 - 99.15 7461 8774
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/7 93 + 14.62 | 7.29 Biocryst Pharmaceuticals BCRX 10.20 +0.5 10.06 - 10.93 42989 27193
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/4 96 + 18.48 | 6.71 BioDelivery Sciences Intl. BDSI 15.00 +4.1 13.88 - 15.07 46255 29051
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/234 131 + 412.02 | 272.02 Biogen IDEC BIIB 409.59 +0.4 400.57 - 412.02 51591 54821
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 177 - 3.03 | 1.20 BioLineRx Ltd. BLRX 2.33 -3.7 2.22 - 2.46 16816 3266
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/21 117 + 111.89 | 55.04 Biomarin Pharmaceuticals BMRN 107.07 -0.1 104.42 - 111.89 64785 52564
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 55/95 101 - 42.00 | 22.23 BioSpecifics Technologies (D) BSTC 38.96 -0.8 37.92 - 41.60 1113 1442
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/39 113 + 7.07 | 2.10 Biota Holdings Ltd. BOTA 2.52 +2.4 2.39 - 2.59 5528 1235
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/19 128 + 4.64 | 2.21 Biotime Inc. BTX 4.20 +1.7 3.90 - 4.33 6898 2942
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/37 227 + 106.23 | 17.40 bluebird bio BLUE 95.32 +2.1 92.04 - 97.00 25208 22766
135 + 8.47 | 2.81 Brainstorm Cell Therapeutics BCLI 4.25 +8.4 3.80 - 4.47 25192 4994
140 - 33.48 | 6.51 Calithera Biosciences CALA 15.22 -6.1 15.15 - 16.71 1561 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1443
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/14 148 + 34.93 | 15.76 Cambrex Corp. CBM 34.25 +2.1 31.82 - 34.93 20700 16964
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 108 + 6.24 | 2.29 Can-Fite BioPharma CANF 4.50 +8.4 3.89 - 4.80 11703 2883
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/18 109 - 23.25 | 7.53 Cara Therapeutics CARA 10.25 -6.1 9.96 - 10.91 6255 4259
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/33 96 - 2.09 | 1.07 CASI Pharmaceuticals, Inc. CASI 1.62 -1.8 1.53 - 1.68 637 157
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 8/25 167 + 1.90 | 0.54 Cel Sci Corp CVM 1.04 +16.9 0.87 - 1.08 43877 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 5826
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 19/34 105 - 125.45 | 66.85 Celgene Corp. CELG 121.53 -1.5 120.77 - 125.45 190132 139466
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/11 145 + 20.85 | 7.82 Celladon Corporation CLDN 18.15 +11.4 16.16 - 18.50 26355 18908
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 124 + 28.45 | 10.76 Celldex Therapeutics CLDX 25.54 +20.4 23.25 - 26.49 266063 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 147838
111 - 3.70 | 1.76 Cellectar Biosciences, Inc. CLRB 2.83 -1.1 2.64 - 2.91 398 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 102
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 34/45 81 + 17.90 | 4.72 Cellular Dynamics Int'l ICEL 5.43 +1.3 5.08 - 5.90 2746 1498
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/67 106 - 4.03 | 2.15 Celsion Corporation (D) CLSN 2.89 -8.3 2.88 - 3.30 10943 3543
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/18 17 - 7.10 | 0.82 Celsus Therapeutics CLTX 0.90 -17.4 0.82 - 1.15 16291 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2231
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 18/19 226 + 33.58 | 8.10 Cempra, Inc. CEMP 33.12 +11.9 29.80 - 33.58 48802 33215
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/8 142 + 8.44 | 3.35 Cerulean Pharma Inc. CERU 8.23 +24.1 6.84 - 8.44 1554 889
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/11 104 - 7.03 | 3.48 Cerus Corp. CERS 4.78 -13.1 4.54 - 5.68 103847 44792
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 173 - 9.20 | 4.06 ChemoCentryx Inc. (D) CCXI 8.14 -1.6 7.78 - 8.42 3419 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2662
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 39/50 113 - 43.41 | 14.02 Chimerix, Inc. CMRX 40.48 -3.0 39.52 - 43.41 19756 15378
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 54/133 110 - 79.28 | 31.55 China Biologic Products CBPO 76.60 -0.8 70.72 - 79.05 5245 5171
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/86 47 - 17.40 | 3.07 Cleveland BioLabs CBLI 3.38 -8.7 3.24 - 4.16 10150 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 3358
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 158 + 93.33 | 35.33 Clovis Oncology CLVS 76.46 +3.6 71.57 - 79.80 21788 21073
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/29 154 + 4.10 | 1.34 Codexis, Inc. CDXS 3.53 +1.7 3.26 - 3.60 4390 1917
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 118 - 12.43 | 6.27 Compugen Ltd. CGEN 8.36 -2.0 8.26 - 8.84 5538 2766
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/4 73 + 13.18 | 5.06 Conatus Pharmaceuticals CNAT 6.36 +0.6 6.10 - 6.59 7606 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 3009
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/16 112 - 15.84 | 7.12 Concert Pharmaceuticals CNCE 14.39 -0.8 13.16 - 15.71 7399 4777
153 + 5.50 | 2.50 ContraFect Corp. CFRX 4.33 +3.8 3.78 - 4.49 1663 746
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/13 107 - 4.49 | 1.69 Corcept Therapeutics CORT 3.31 -1.8 3.31 - 3.50 4821 2663
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 127 - 8.49 | 4.30 Corium International CORI 6.92 -1.6 6.77 - 7.10 180 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 117
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 362 + 5.58 | 1.05 CorMedix Inc. CRMD 5.16 +11.5 4.68 - 5.58 60546 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 19036
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/14 108 + 2.88 | 1.45 Coronado Biosciences CNDO 2.57 +6.6 2.37 - 2.88 21423 4897
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/31 105 + 4.22 | 2.00 CTI BioPharma Corp. CTIC 2.34 +2.6 2.27 - 2.45 142995 31207
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 204 - 3.50 | 1.09 Curis Inc CRIS 3.08 -9.4 2.77 - 3.44 186657 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 53038
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/46 50 + 4.14 | 0.51 Cyclacel Pharmaceuticals (D) CYCC 1.50 +89.9 0.71 - 2.13 276031 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 47287
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/8 162 - 13.26 | 3.05 Cytokinetics Inc. (D) CYTK 7.71 -2.9 7.59 - 8.35 21545 11406
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/40 256 + 3.33 | 0.36 Cytori Therapeutics (D) CYTX 1.12 +103.6 0.56 - 1.42 1063230 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 115618
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/42 126 + 6.46 | 2.08 Cytrx Corp. CYTR 3.23 +1.6 3.10 - 3.44 30478 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 11327
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/45 125 + 3.55 | 0.74 DARA Biosciences (D) DARA 0.99 +11.2 0.82 - 1.05 28263 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 3296
95 + 22.94 | 12.68 Dermira, Inc. DERM 16.73 +4.6 15.87 - 17.99 1077 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 833
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/4 203 - 42.50 | 8.00 Dicerna Pharmaceuticals DRNA 24.43 -6.1 22.55 - 26.06 4910 3867
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 12/12 134 + 15.86 | 8.00 Dipexium Pharmaceuticals DPRX 14.23 +4.4 12.94 - 15.14 2014 1065
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/42 101 + 2.75 | 0.99 Discovery Laboratories DSCO 1.61 +5.9 1.44 - 1.69 21349 6068
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 30/31 106 - 17.20 | 6.05 Dyax DYAX 15.11 -5.3 14.63 - 17.20 53539 37570
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/17 245 + 19.85 | 3.81 Egalet Corporation EGLT 15.01 +3.5 12.42 - 16.00 4420 2549
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/5 91 - 17.82 | 9.50 Eleven Biotherapeutics EBIO 10.57 -2.6 10.18 - 11.44 958 783
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/11 118 + 30.74 | 19.31 Emergent BioSolutions EBS 29.97 nc 29.26 - 30.74 7001 6765
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 6/63 75 + 52.58 | 31.22 Enanta Pharmaceuticals ENTA 35.82 -0.2 34.73 - 36.93 13209 11824
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 9/37 88 + 33.70 | 5.01 Endocyte, Inc. ECYT 5.80 +1.9 5.43 - 5.99 20651 10199
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/12 95 - 1.83 | 0.80 Enzon, Inc. ENZN 1.05 -4.6 1.04 - 1.20 9088 2246
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/36 100 + 28.90 | 5.38 Enzymotec Ltd. ENZY 8.29 +17.4 7.02 - 8.40 3300 2024
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/65 207 + 17.40 | 3.78 EPIRUS Biopharmaceuticals EPRS 10.53 +21.9 8.50 - 10.74 23938 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 9605
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/14 101 + 40.98 | 16.51 Epizyme, Inc. EPZM 23.52 +3.3 22.59 - 24.30 10169 8793
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 31/33 194 - 70.87 | 12.75 Esperion Therapeutics Inc ESPR 62.45 -5.4 62.41 - 66.54 16848 14279
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/28 107 - 20.00 | 8.07 Evogene Ltd. EVGN 10.06 -0.6 10.02 - 10.54 165 69
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/60 89 - 29.97 | 10.69 EXACT Sciences EXAS 22.47 -12.4 20.35 - 26.00 229620 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 131851
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/45 173 + 7.58 | 1.26 Exelixis Inc EXEL 2.93 +6.9 2.50 - 3.00 286859 76597
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/35 130 - 13.55 | 3.50 Fate Therapeutics FATE 4.98 -0.4 4.61 - 5.18 1716 526
138 + 40.59 | 20.10 FibroGen, Inc. FGEN 31.82 +5.5 29.90 - 32.78 6095 4690
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 123 - 28.47 | 10.50 Five Prime Therapeutics FPRX 25.74 -2.0 25.41 - 28.36 8725 6577
0 + 19.50 | 12.55 Flex Pharma, Inc. FLKS 17.39 +18.2 14.52 - 18.05 6056 3723
166 - 11.00 | 4.75 Foamix Pharmaceuticals Ltd. FOMX 8.96 -2.4 8.50 - 9.92 10347 4588
115 - 27.44 | 15.75 Forward Pharma A/S FWP 23.28 -1.3 22.69 - 24.25 1508 1193
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/44 99 - 4.04 | 1.43 Galena Biopharma GALE 1.80 -2.2 1.78 - 1.93 52451 10805
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 8/12 158 + 18.73 | 4.58 Galmed Pharmaceuticals GLMD 9.49 +18.0 7.82 - 10.00 5458 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 2344
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/17 93 - 23.99 | 6.15 Genocea Biosciences GNCA 8.63 -4.1 8.56 - 9.75 2540 1658
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 139 - 4.67 | 1.61 Genvec, Inc. GNVC 3.18 -5.6 3.17 - 3.56 3863 1460
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/14 81 - 4.62 | 1.31 Geron Corp GERN 3.02 -4.4 3.00 - 3.18 87967 24060
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/165 101 + 116.83 | 63.50 Gilead Sciences GILD 103.53 +0.9 102.71 - 105.42 386645 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 241428
113 - 15.00 | 4.29 GlobeImmune, Inc. GBIM 7.56 -0.7 6.90 - 7.62 1134 510
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/78 123 + 2.03 | 0.41 GTx Inc. (D) GTXI 0.80 +14.3 0.69 - 0.83 7373 1442
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 169 - 15.94 | 6.88 Halozyme Therapeutics HALO 15.07 -2.0 14.52 - 15.94 56835 36860
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/10 131 - 8.00 | 3.60 Heat Biologics HTBX 6.66 -2.5 6.20 - 6.97 1028 453
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/33 91 + 0.49 | 0.21 Hemispherx Biopharma Inc HEB 0.24 nc 0.23 - 0.25 49793 4719
0 + 12.97 | 7.04 Histogenics Corporation HSGX 10.67 +11.2 9.47 - 10.70 1354 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 871
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 142 + 31.31 | 20.23 Hyperion Therapeutics HPTX 29.55 +7.8 26.61 - 30.59 7982 7557
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/3 93 + 3.48 | 0.24 iBio, Inc. IBIO 1.00 +7.5 0.87 - 1.08 136818 15101
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 154 + 6.87 | 1.94 Idera Pharmaceuticals (D) IDRA 4.87 +4.5 4.66 - 5.24 136432 47681
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/104 108 + 11.74 | 3.76 IGI Laboratories Inc. IG 11.52 +6.6 10.82 - 11.74 44886 16696
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/12 124 + 10.64 | 5.36 Ignyta, Inc. RXDX 8.54 +19.1 7.05 - 9.23 2421 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1053
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/122 101 - 213.33 | 127.69 Illumina Inc. ILMN 195.46 -3.8 193.18 - 203.75 34596 36412
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 20/32 134 - 7.22 | 3.30 Immucell Corp ICCC 6.65 -0.8 6.39 - 7.18 159 81
68 - 40.13 | 11.51 Immune Design Corp. IMDZ 22.04 -8.9 21.79 - 24.64 705 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 922
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/63 93 + 1.46 | 0.53 ImmunoCellular Therapeutics IMUC 0.57 +1.8 0.56 - 0.60 53707 10781
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/68 73 + 17.49 | 5.34 Immunogen Inc. IMGN 7.60 -0.3 7.27 - 7.89 41032 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 23172
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/13 97 + 5.48 | 3.04 Immunomedics IMMU 4.08 +2.3 3.99 - 4.11 34488 15696
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/51 87 - 9.62 | 4.71 Imprimis Pharmaceuticals IMMY 7.50 -2.3 7.40 - 7.88 345 135
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/16 112 + 88.44 | 40.30 Incyte Corporation INCY 85.85 +4.1 80.45 - 88.44 57298 45108
Bearish Crossover (aka 'Newly Bearish' Trend). The stock's Trend Category has changed from BULLISH to BEARISH. The 13-week MA, which was above the 40-week MA a week previous, has now moved below it. A stock exhibiting this Trends Symbol is in the 1st week of its new BEARISH Trend Category. Trading implications: generally considered a trade exit signal. 1/1 98 + 5.60 | 5.60 Indevus Pharmaceuticals Inc IDEV 5.60 nc nt nt nt
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/23 99 - 18.25 | 8.40 Infinity Pharmaceuticals INFI 15.20 -3.1 13.84 - 16.12 37254 29162
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/7 72 + 15.56 | 6.33 Inovio Pharmaceuticals, Inc. INO 7.08 +2.9 6.33 - 7.18 37263 13879
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 129 + 20.49 | 11.25 Insmed, Inc. INSM 18.54 +5.5 16.96 - 18.85 18897 15447
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 18/19 152 + 61.52 | 20.52 Insys Therapeutics INSY 60.06 +14.6 52.48 - 61.52 23111 18230
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/11 152 - 45.10 | 13.13 Intrexon Corp. XON 41.06 -1.7 39.29 - 45.10 76040 43980
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/230 94 - 183.84 | 120.38 Jazz Pharmaceuticals JAZZ 170.09 -1.4 169.61 - 180.39 51524 43042
0 + 61.70 | 34.71 Juno Therapeutics, Inc. JUNO 46.92 +3.1 44.44 - 49.00 48143 28244
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/5 75 + 18.48 | 10.85 Keryx Biopharmaceuticals KERX 12.16 +0.8 11.51 - 12.43 85319 49935
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 25/25 69 - 26.99 | 5.98 Kindred Biosciences KIN 6.71 -0.9 6.65 - 6.94 2214 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1643
153 + 89.21 | 21.00 Kite Pharma KITE 65.44 +4.2 63.00 - 69.00 44995 30486
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 18/18 179 + 22.80 | 6.17 La Jolla Pharmaceutical (D) LJPC 20.33 +8.8 18.62 - 20.50 4481 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 3323
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/62 91 + 1.91 | 0.80 Lexicon Pharmaceuticals LXRX 0.94 +1.1 0.91 - 0.95 119563 15199
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/30 100 - 80.21 | 41.99 Ligand Pharmaceuticals LGND 55.07 -4.3 54.92 - 58.68 15906 14417
122 - 16.45 | 9.90 Loxo Oncology, Inc. LOXO 12.84 -6.0 12.72 - 13.81 1519 823
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/64 112 - 5.17 | 2.30 Lpath Inc. LPTN 2.93 -3.6 2.76 - 3.08 1063 293
121 - 14.30 | 6.82 Macrocure Ltd. MCUR 9.55 -6.4 9.13 - 10.47 1318 638
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 11/12 120 - 39.90 | 17.31 MacroGenics, Inc. MGNX 34.57 -3.6 33.61 - 35.67 10912 8970
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/20 104 - 11.48 | 3.80 MannKind MNKD 6.52 -5.5 6.41 - 7.00 271465 83031
166 - 16.60 | 5.49 Marinus Pharmaceuticals MRNS 11.46 -1.6 10.93 - 12.00 794 492
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/29 109 + 0.93 | 0.40 Mast Therapeutics, Inc. MSTX 0.52 +4.0 0.49 - 0.57 84283 7585
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 186 + 8.79 | 3.68 Medgenics, Inc. MDGN 7.84 +3.8 7.56 - 8.20 4660 2399
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/25 114 + 4.80 | 1.66 Medicinova MNOV 3.54 +0.9 3.33 - 3.65 1196 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 437
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/36 100 + 120.72 | 54.37 Medivation MDVN 117.53 +6.9 109.32 - 120.72 62974 57781
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 9/11 128 + 19.31 | 4.60 MediWound Ltd. MDWD 7.71 +2.5 7.33 - 8.40 1975 1005
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/57 115 - 12.00 | 4.13 Merrimack Pharmaceuticals MACK 10.72 -2.6 10.24 - 11.19 47430 30559
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 4/17 151 + 2.59 | 1.15 Merus Labs International MSLI 2.15 +14.4 1.75 - 2.30 2020 960
107 - 10.00 | 4.08 Minerva Neurosciences NERV 5.14 -3.4 4.81 - 5.43 2202 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1126
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/3 158 + 24.47 | 13.69 Mirati Therapeutics Inc MRTX 23.77 +0.3 22.39 - 24.47 4188 2801
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 3/6 69 - 22.44 | 7.80 NanoString Technologies NSTG 10.51 -14.4 9.95 - 12.31 14807 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 8289
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/8 128 - 2.12 | 0.97 Navidea Biopharmaceuticals NAVB 1.62 -1.2 1.58 - 1.67 48653 5758
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/30 77 - 17.53 | 10.10 Nektar Therapeutics NKTR 13.07 -4.0 12.27 - 13.82 82278 52925
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/47 94 - 7.98 | 3.08 Neostem NBS 3.76 -7.6 3.72 - 4.10 8780 3118
61 - 14.10 | 6.11 Neothetics, Inc. NEOT 6.71 -1.5 6.61 - 6.90 1272 438
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/65 91 + 2.88 | 1.11 Neptune Tech & Bioresources NEPT 1.87 +2.8 1.75 - 1.90 3725 1580
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 8/24 131 - 4.81 | 2.12 Neuralstem CUR 3.76 -1.1 3.55 - 3.85 35160 10880
186 + 19.07 | 5.67 NeuroDerm Ltd. NDRM 13.83 +19.4 11.50 - 14.21 11218 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 5066
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/17 108 + 44.00 | 17.32 NewLink Genetics Corp. NLNK 43.08 +8.4 39.18 - 43.19 23634 18274
0 + 11.00 | 8.40 Nexvet Biopharma plc NVET 10.03 +5.6 9.07 - 11.00 1970 796
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 135 + 10.64 | 3.79 Northwest Biotherapeutics Inc NWBO 7.37 +15.7 6.25 - 7.60 44979 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 19100
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 28/62 75 - 1.38 | 0.42 NovaBay Pharmaceuticals NBY 0.54 -5.3 0.42 - 0.59 7304 1239
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 16/17 168 - 9.83 | 3.34 Novavax Inc. NVAX 9.15 -3.8 8.40 - 9.83 280871 116651
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 10/11 136 + 46.01 | 22.11 NPS Pharmaceuticals NPSP 45.97 nc nt nt Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. nt
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/4 70 - 17.01 | 4.47 Ocera Therapeutics OCRX 5.65 -5.8 5.55 - 6.10 5056 1850
208 + 36.98 | 11.90 Ocular Therapeutix, Inc. OCUL 35.77 +14.0 31.10 - 36.98 10323 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 6614
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 1/2 99 + 20.00 | 6.01 Ohr Pharmaceutical OHRP 7.69 +7.6 6.96 - 8.15 13687 6960
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/78 92 - 25.84 | 9.76 Omeros OMER 20.87 -1.8 20.30 - 21.33 20593 12770
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/41 107 + 14.25 | 1.92 OncoGenex Pharmaceuticals OGXI 2.30 +1.3 2.10 - 2.36 5682 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2185
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/92 102 + 2.07 | 0.40 Oncolytics Biotech (D) ONCY 0.73 +9.0 0.58 - 0.82 129245 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 11701
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 111 - 39.50 | 16.57 OncoMed Pharmaceuticals OMED 24.98 -7.7 24.53 - 27.98 6837 6109
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 25/45 47 - 8.50 | 2.15 Onconova Therapeutics ONTX 2.29 -3.8 2.25 - 2.46 2269 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 709
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/24 90 + 4.08 | 1.48 Oncothyreon Inc. ONTY 1.60 +3.2 1.56 - 1.73 62766 19297
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 98 + 124.70 | 124.70 Onyx Pharmaceuticals ONXX 124.70 nc nt nt nt
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 34/47 91 + 2.20 | 0.67 Opexa Therapeutics (D) OPXA 0.79 +8.2 0.67 - 0.91 14456 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 1788
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 22/36 122 - 58.29 | 30.13 Ophthotech Corporation OPHT 53.74 -3.7 51.51 - 58.29 17114 15335
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/45 121 + 3.87 | 0.70 Oragenics Inc. OGEN 1.15 +6.5 1.00 - 1.18 2563 570
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 26/40 74 - 15.95 | 4.31 Oramed Pharmaceuticals ORMP 4.52 -3.8 4.38 - 4.75 1821 608
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 5/6 129 + 17.69 | 11.80 Osiris Therapeutics OSIR 17.27 +4.5 16.43 - 17.69 5492 3739
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 27/28 177 - 52.94 | 5.51 Ovascience Inc. OVAS 45.51 -1.2 44.41 - 49.37 15545 9648
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/34 93 + 5.40 | 1.48 Oxigene, Inc. OXGN 1.76 +1.2 1.66 - 1.84 22043 3917
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/17 92 - 8.78 | 3.87 Pacific Biosc. of California PACB 6.30 -8.0 6.17 - 7.00 36812 20626
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 2/29 103 - 6.22 | 1.61 Pain Therapeutics Inc PTIE 1.90 -3.1 1.90 - 2.00 4844 2634
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/14 151 - 39.80 | 8.99 Paratek Pharmaceuticals, Inc. PRTK 29.23 -6.9 28.62 - 32.00 1722 1129
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 18/19 83 - 10.26 | 6.52 PDL BioPharma PDLI 6.98 -4.1 6.52 - 7.41 259850 97366
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/28 94 + 3.18 | 1.19 Peregrine Pharmaceuticals PPHM 1.41 +10.2 1.21 - 1.52 93852 15946
181 + 15.14 | 5.28 Pfenex Inc. PFNX 14.70 +15.3 12.69 - 15.14 8807 5218
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/24 152 + 231.09 | 82.51 Pharmacyclics PCYC 215.93 +21.6 174.04 - 231.09 174571 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 132688
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/2 97 - 2.59 | 1.19 PharmAthene PIP 1.68 -1.8 1.60 - 1.71 4906 813
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/39 118 + 4.36 | 2.32 Pluristem Therapeutics PSTI 3.04 +2.0 2.98 - 3.09 4621 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1858
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/29 133 + 40.55 | 19.59 Portola Pharmaceuticals PTLA 38.08 +0.8 36.91 - 40.55 21175 16804
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 25/42 67 + 11.59 | 1.07 Prana Biotechnology Ltd PRAN 1.11 nc 1.08 - 1.25 35475 3925
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/29 105 + 1.56 | 0.62 Prima BioMed (D) PBMD 0.99 +23.8 0.82 - 1.03 1191 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 223
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/27 92 + 7.84 | 3.10 Progenics Pharmaceutical PGNX 6.51 +4.5 6.12 - 6.97 45197 24208
122 - 23.02 | 11.00 ProQR Therapeutics N.V. PRQR 18.83 -0.7 18.33 - 21.00 3046 2471
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/42 90 - 5.30 | 1.71 Protalix BioTherapeutics PLX 1.92 -2.0 1.91 - 2.04 8377 2752
101 + 12.65 | 8.57 Proteon Therapeutics, Inc. PRTO 10.81 +2.4 10.52 - 11.04 504 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 287
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 4/5 108 + 49.24 | 16.71 Prothena Corporation plc PRTA 26.58 -0.2 24.92 - 31.15 16770 13096
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 32/33 157 + 75.94 | 14.51 PTC Therapeutics PTCT 71.33 +29.2 54.67 - 75.94 79879 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 60531
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 7/30 92 + 279.37 | 53.63 Puma Biotechnology PBYI 213.01 +2.5 195.13 - 214.69 14434 14744
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/33 99 - 6.68 | 3.35 QLT Inc. QLTI 4.02 -0.5 3.90 - 4.08 6359 3125
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/30 92 + 139.40 | 24.53 Receptos, Inc. RCPT 126.64 +1.0 118.28 - 133.76 31977 29519
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 10/13 121 + 9.88 | 2.36 Recro Pharma REPH 3.41 +5.6 3.12 - 3.49 662 251
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 7/35 136 + 14.10 | 0.80 Regado BioSciences RGDO 1.15 +1.8 1.07 - 1.25 14035 3459
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 33/34 98 - 437.64 | 269.50 Regeneron Pharmaceuticals REGN 413.84 -2.4 411.04 - 432.38 38557 40882
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/18 97 - 25.60 | 5.40 Regulus Therapeutics Inc RGLS 18.52 -1.0 17.79 - 19.49 21841 14704
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 13/49 80 - 2.75 | 1.07 Reliv' International RELV 1.09 -7.6 1.07 - 1.16 510 149
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/9 153 + 52.74 | 17.60 Relypsa, Inc. RLYP 38.80 +10.1 35.27 - 39.50 36482 28373
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 8/131 110 + 26.75 | 12.04 Repligen Corp. RGEN 25.71 +1.0 24.68 - 26.70 13165 11507
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/62 106 - 22.55 | 5.92 Repros Therapeutics RPRX 9.21 -0.7 8.66 - 9.60 10592 6369
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/17 96 + 39.86 | 14.02 Revance Therapeutics RVNC 16.05 +1.8 15.60 - 16.81 4172 2794
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/32 117 + 1.52 | 0.65 Rexahn Pharmaceuticals RNN 0.80 nc 0.75 - 0.82 28337 3775
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/62 85 - 1.08 | 0.11 Rock Creek Pharmaceuticals RCPI 0.13 -13.3 0.11 - 0.16 84753 6177
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/11 93 - 8.47 | 3.31 Ruthigen, Inc. RTGN 3.87 -4.7 3.85 - 4.20 374 147
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 11/16 58 + 6.50 | 0.91 RXI Pharmaceuticals RXII 1.16 +0.9 1.11 - 1.22 5689 924
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/7 137 - 24.69 | 9.39 Sangamo BioSciences SGMO 16.82 -0.8 15.95 - 17.80 41645 26289
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/27 81 - 40.00 | 11.33 Sarepta Therapeutics, Inc. SRPT 13.90 -8.6 13.12 - 15.74 65420 39139
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 2/41 98 + 55.46 | 30.05 Seattle Genetics Inc SGEN 36.25 +3.7 33.40 - 37.89 65939 45358
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 2/9 115 + 4.19 | 2.25 Sequenom Inc. SQNM 3.50 +0.3 3.45 - 3.57 30505 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 10827
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/9 111 + 264.98 | 141.66 Shire plc SHPG 241.91 +2.0 236.88 - 248.91 38315 35269
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/62 131 + 3.49 | 0.99 SIGA Technologies (Q) SIGA 2.27 +10.2 2.00 - 2.35 8041 3363
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 8/37 97 - 8.14 | 4.51 Sinovac Biotech SVA 4.94 -1.2 4.86 - 5.00 3620 1835
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 330 + 16.40 | 3.10 Sorrento Therapeutics SRNE 12.92 +4.5 12.18 - 13.50 13280 7229
0 + 63.63 | 40.16 Spark Therapeutics, Inc. ONCE 57.59 +12.0 52.01 - 63.63 14943 11684
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/13 85 - 9.27 | 5.65 Spectrum Pharmaceuticals Inc SPPI 6.23 -16.5 5.65 - 6.46 157063 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 67652
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 1/21 97 + 2.43 | 0.84 StemCells, Inc. STEM 1.12 +2.8 1.05 - 1.13 16170 3031
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 1/10 100 + 27.17 | 10.50 Stemline Therapeutics STML 15.19 +7.7 13.90 - 16.97 8315 5558
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/18 93 - 8.46 | 1.00 Sunesis Pharmaceuticals SNSS 2.22 -5.5 2.21 - 2.42 33846 11226
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 119 - 122.88 | 60.19 Synageva BioPharma GEVA 98.73 -3.6 96.08 - 105.46 12600 13735
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 33/48 74 + 6.60 | 2.18 Synta Pharmaceuticals SNTA 2.40 +3.5 2.27 - 2.48 26970 10380
Bullish Crossover (aka 'Newly Bullish' Trend). The stock's Trend Category has changed from BEARISH to BULLISH. The 13-week MA, which was below the 40-week MA a week previous, has now moved above it. A stock in this sub-category is in the 1st week of its new BULLISH Trend Category. Trading implications: often considered a good trade entry signal. 1/1 133 + 3.64 | 1.16 Synthetic Biologics Inc. SYN 2.32 +12.6 2.10 - 2.35 63096 13561
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 7/61 106 + 5.23 | 2.25 Targacept TRGT 2.63 +1.2 2.55 - 2.64 1886 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 657
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 23/37 83 - 8.35 | 3.01 Tenax Therapeutics, Inc. TENX 3.15 -4.8 3.03 - 3.33 1796 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 626
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/14 152 + 54.26 | 22.15 TESARO, Inc. TSRO 53.33 +20.7 46.12 - 54.26 33265 23073
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 5/7 98 - 9.28 | 3.51 TetraLogic Pharmaceuticals TLOG 4.82 -2.4 4.55 - 5.07 1585 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 617
96 + 18.88 | 7.20 TG Therapeutics TGTX 14.51 +7.5 13.45 - 15.37 31950 16514
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/61 117 - 31.80 | 10.58 Theravance THRX 18.06 -0.9 16.73 - 18.63 44871 33856
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 3/3 135 + 35.68 | 13.11 Theravance Biopharma TBPH 21.73 +11.3 19.08 - 22.00 8798 6877
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 9/46 148 + 5.58 | 2.58 Threshold Pharmaceuticals THLD 4.37 +0.5 4.21 - 4.52 40923 16306
101 + 30.00 | 9.67 Tokai Pharmaceuticals, Inc. TKAI 15.13 +4.4 13.61 - 15.14 1935 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1612
0 + 14.97 | 9.02 TRACON Pharmaceuticals, Inc. TCON 13.43 +32.5 9.75 - 14.97 13014 5052
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 13/28 105 - 8.22 | 4.36 Transition Therapeutics Inc TTHI 6.84 -3.0 6.83 - 7.10 717 323
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 5/18 101 - 9.95 | 3.80 Trevena, Inc. TRVN 5.39 -0.9 5.05 - 5.60 4108 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 2541
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/17 121 + 7.10 | 2.97 Trovagene, Inc. TROV 5.65 +12.8 4.75 - 5.73 9948 3937
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 6/7 122 - 69.77 | 32.02 Ultragenyx Pharmaceutical RARE 54.27 -2.3 52.64 - 56.58 10668 9922
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 1/2 81 - 19.25 | 8.34 Vanda Pharmaceuticals VNDA 10.76 -5.9 10.40 - 11.44 44795 25726
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 3/31 114 - 7.45 | 1.90 VBI Vaccines Inc. VBIV 2.76 -2.5 2.72 - 2.90 166 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 65
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 5/27 132 + 19.00 | 6.01 Veracyte, Inc. VCYT 8.79 nc 8.45 - 8.99 1629 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 1277
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 4/5 79 - 14.92 | 6.78 Verastem, Inc. VSTM 7.44 -5.9 7.41 - 8.10 17494 9026
Weak Bearish Trend. The closing price is above the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend is weakening, and will result in a Bullish Crossover m at some point unless the stock's price falters below the 13-week MA envelope. Trading implication: generally considered an alert that the bearish trend has abated and that often implies a trade entry signal. 6/27 126 + 7.00 | 2.55 Vericel Corporation VCEL 3.60 nc 3.38 - 3.70 3933 1401
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 2/34 100 + 127.69 | 59.79 Vertex Pharmaceuticals VRTX 119.43 +0.7 114.71 - 121.50 62782 56718
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 17/40 92 + 1.60 | 0.89 Vical Inc. VICL 1.02 +1.0 1.00 - 1.05 17955 3833
56 - 23.35 | 5.41 Vitae Pharmaceuticals, Inc. VTAE 11.62 -18.2 10.57 - 14.35 10177 5267
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 3/7 105 + 35.20 | 10.66 Vital Therapies VTL 22.15 +0.9 21.68 - 22.87 6638 2493
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 36/76 77 - 6.40 | 2.41 Vivus Inc. VVUS 2.61 -9.4 2.50 - 2.92 95548 30872
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 15/16 137 + 19.50 | 7.82 Xencor, Inc. XNCR 15.60 +3.6 13.71 - 15.95 36380 Unusually High Volume Indicator. The stock's trading volume for the week is at least double (>= 200%) its average weekly volume (13-week moving average). Trading implications: The High Volume indicator, concurrent with a Bullish Crossover symbol, has proven to be a highly successful identifier of stocks verging on a long-term bullish trend. Generally, high volume should support price advances, and at times can precede or anticipate them. 16821
144 + 23.50 | 12.06 Xenon Pharmaceuticals XENE 19.34 -0.2 18.75 - 20.49 1208 Unusually Low Volume Indicator. The stock's trading volume for the week is no more than one-half (<= 50%) its average weekly volume (13-week moving average). Trading implications: The Low Volume indicator, concurrent with advancing price, offers both a warning for Bullish stocks and a possible Buy trading signal for Bearish stocks. 867
Weak Bullish Trend. The closing price is below the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend is weakening, and will ultimately result in a Bearish Crossover unless the stock's price can recover above the 13-week MA envelope. Trading implication: generally still considered positive in terms of holding, although it can be a strong exit signal. At the minimum, this alert calls for a review of the holding. 4/20 76 - 9.60 | 3.15 XenoPort XNPT 6.85 -4.7 6.70 - 7.46 31481 17822
(Strong) Bearish Trend. The closing price is below the upper limit of the 13-week MA envelope. This indicates that the short-term bearish trend of the stock's price remains relatively strong. Trading implication: generally considered a negative signal for holding. Trade exit signals already triggered. 6/7 64 - 9.57 | 3.22 Xoma Corp. XOMA 3.69 -8.9 3.61 - 4.33 116239 39599
161 - 43.03 | 16.01 Zafgen, Inc. ZFGN 38.65 -4.9 36.16 - 43.03 8254 7134
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding. 9/10 263 + 12.02 | 2.31 ZIOPHARM Oncology ZIOP 11.26 +17.8 9.50 - 12.02 305548 114835
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop drugs through the structure-guided drug design process. Its product candidates include peramivir, an intravenous neuraminidase inhibitor, which is approved for seasonal influenza in Japan and Korea, as well as to treat acute influenza; ulodesine, an oral purine nucleoside phosphorylase inhibitor, which has completed Phase II clinical trials for the treatment of gout; and forodesine, an oral purine nucleoside phosphorylase inhibitor that is in Phase II clinical trials for oncology. The companys product candidates also comprise BCX4161, a Phase II oral serine protease inhibitor for hereditary angioedema (HAE); and BCX4430, a preclinical, RNA dependent-RNA polymerase inhibitor for treating Filoviruses, including hemorrhagic fever viruses. Its pre-clinical products also include Two 2nd generation HAE compounds for the prevention of HAE attacks. It has collaborative relationships with Mundipharma International Holdings Limited for the development and commercialization of forodesine; and Shionogi & Co., Ltd. and Green Cross Corporation for the development and commercialization of peramivir. Biocryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Company Website :
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us